AbCellera Results Presentation Deck

Q2 2021 BUSINESS UPDATE COPYRIGHT © ABCELLERA 7 EMPOWER NEW MODALITIES FOR NEXT-GEN THERAPIES Our platform is an operating system designed to support many next-gen modalities, including: Y IgGs, IgMs, IgAs single chains (scFvs) CAR-T Cell therapies Y y bispecific antibodies radioisotope conjugates CNS-delivered antibodies

View entire presentation